Chimeric D2/D3 dopamine receptors efficiently inhibit adenylyl cyclase in HEK 293 cells

J Neurochem. 1996 Jul;67(1):212-9. doi: 10.1046/j.1471-4159.1996.67010212.x.


Despite a high degree of sequence homology, the dopamine D2 and D3 receptors have substantially different second messenger coupling properties. We have used chimeric D2/D3 receptors to investigate the contribution of the intracellular loops to the signaling properties of these receptors. In HEK 293 cells, D2 receptors inhibit prostaglandin E1-stimulated cyclic AMP levels by >90%, whereas D3 receptors inhibit cyclic AMP accumulation by only 20%. In chimeras that have the second or third intracellular loop, or both loops simultaneously, switched between the D2 and D3 receptors, the maximal inhibition of adenylyl cyclase is 60-90%. In addition, the potency of quinpirole to inhibit adenylyl cyclase activity at some of the chimeras is altered compared with the wild-type receptors. It appears that the intracellular loops of the D3 receptor are capable of interacting with G proteins, as when these loops are expressed in the D2 receptor, the chimeras inhibit adenylyl cyclase similarly to the wild-type D2 receptor. Our data suggest that the overall conformation of the D3 receptor may be such that it interacts with G proteins only weakly, but when the intracellular loops are expressed in another context or the D3 receptor structure is altered by the introduction of D2 receptor sequence, this constraint may be lifted.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenylyl Cyclase Inhibitors*
  • Adenylyl Cyclases / metabolism
  • Cell Line / chemistry
  • Cell Line / enzymology
  • Cyclic AMP / antagonists & inhibitors
  • Humans
  • Kidney / cytology
  • Protein Conformation
  • Receptors, Dopamine D2 / chemistry
  • Receptors, Dopamine D2 / physiology*
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / physiology


  • Adenylyl Cyclase Inhibitors
  • Receptors, Dopamine D2
  • Recombinant Fusion Proteins
  • Cyclic AMP
  • Adenylyl Cyclases